Hydroxychloroquine and chloroquine for survival in COVID-19:  an international collaborative  meta-analysis of randomized trials

doi:10.17605/OSF.IO/QESV4

Title	Authors

Home

For this project, we use our COVID-evidence database. COVID-evidence is supported by the Swiss National Science Foundation (Project ID 196190) and a large collaboration of researchers from Switzerland, the US, China, Canada, UK, France, Germany, Austria, Sweden, Netherlands, and other countries. COVID-evidence | https://covid-evidence.org/ Universität Basel - Departement Klinische Forschung Universitätsspital Basel Meta-Research Innovation Center at Stanford (METRICS) | https://metrics.stanford.edu/ Meta-Research Innovation Center Berlin (METRIC-B) | https://metricberlin.netlify.app//

OSF does not support the use of Internet Explorer. For optimal performance, please switch to another browser.

This website relies on cookies to help provide a better user experience. By clicking Accept or continuing to use the site, you agree. For more information, see our Privacy Policy and information on cookie use.

Start managing your projects on the OSF today.

Free and easy to use, the Open Science Framework supports the entire research lifecycle: planning, execution, reporting, archiving, and discovery.

Create an Account Learn More Hide this message

Main content

Home

Menu

Start managing your projects on the OSF today.

Main content

Links to this project

Home

Menu

Add new wiki page

Page permissions have changed

Wiki page deleted

Connected to the collaborative wiki

Connecting to the collaborative wiki

Collaborative wiki is unavailable

Browser unsupported

Start managing your projects on the OSF today.